Conspiracy Theories Newsletter, 2026 Edition
March 26, 2026
Partners Tiffany Rider, James W. Attridge, Daniel K. Oakes, Jacklin Chou Lem, and Mary Helen Wimberly co-authored the 2026 edition of Axinn’s Conspiracy Theories newsletter, which examines the direction of criminal antitrust enforcement under the Trump Administration.
Now a year in, the Trump 2.0 commitment to continued and aggressive criminal antitrust enforcement is bearing fruit, bolstered by a “frenzy” of tips from the newly established whistleblower rewards program. The Antitrust Division initiated 100 new investigations in 2025 and filed 24% more cases in 2025 compared to 2024. Ongoing investigations and litigation continue to focus on procurement, consumer-facing markets, and labor markets, while exploring novel theories of harm involving the use of AI and environmental, social, and governance efforts. Even states are dusting off criminal authority with increasing frequency, and the DOJ continues to emphasize the need to invest in and update compliance efforts, or risk the possibility of criminal investigation, prosecution, and “significant prison sentences” for culpable executives.
The newsletter offers predictions and practical insights into what businesses should anticipate from the DOJ’s Antitrust Division in the year ahead.
Special thanks to associates Tasneem Chowdhury, Chandler Gordon, Aigerim Saudabayeva, and Duncan Weals for their valuable contributions.
Click here to read the newsletter.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
What Happens in Vegas Stays in Vegas: Third Circuit Parts Ways with Ninth Circuit and Reinstates Atlantic City Algorithmic-Pricing Claim
Axinn Viewpoints
Antitrust
What Should Directors Be Asking? Antitrust in the Boardroom
Podcast
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
Intellectual Property
National Bar Association Corporate Counsel Leadership Summit
Speaking Engagement
Antitrust